The ophthalmologic drug developer has gone public three years after being founded by WuXi AppTec-backed 6 Dimensions Capital.

The banking software provider's shares have nearly tripled following an offering in which it floated well above its range.

The online employee and further education provider has listed on TSE’s Mothers Market, allowing Tokyo Institute of Technology to exit.

The Baidu and SoftBank-backed on-demand staff provider floated in the middle of its range in a US offering and its market cap currently stands at about $600m.

The GSK, Amgen and Novo-backed cancer drug developer went public in an upsized offering priced above its range.

New World Development and China Mobile-backed gay social and dating app developer Blued raised $84.8m and has seen its shares nearly double in price post-IPO.

The Crooz, InterWorks, MyNavi, Sega Sammy and Vector-backed IT human resources provider could raise up to $21m in its initial public offering.

CAS-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

Baylor College spinout AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

Lenovo, iFlytek, Alibaba and Tuling Century-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.